Vanda Pharmaceuticals (VNDA) stock saw a 9% premarket drop after FDA rejection of its therapy for gastroparesis, citing need ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Time spent above, not below, the target glucose range was associated with mortality in a study of adults with type 2 diabetes ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

The device is a variant of Neuralink's brain implant technology, in this case designed to "enable even those who have lost both eyes" to see, according to owner Elon Musk. Separately, progress is ...